Skip to main content

Table 2 Ezatiostat Hydrochloride Liposomes for Injection Treatment Administration

From: Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

Phase 1

Doase Cohort (mg/m2)

# of Patients

Total # Cycles Administered

Median # of Cycles per Patient (Range)

50

6

16

3 (1–5)

100

3

10

4 (2–4)

200

3

19

7 (4–8)

400

7

36

8 (1–8)

600

7

32

5 (1–8)

TOTAL

26

113

4 (1 – 8)

Phase 2

Treatment (600 mg/m 2 )

# of Patients

Total # Cycles Administered

Median # of Cycles per Patient (Range)

Dose Schedule 1

10

93

8 (4 – 17)

Dose Schedule 2

18

117

4 (1 – 19)

TOTAL

28

210

7 (1 – 19)